BioWorld

Feb. 12, 2004

View Archived Issues

What Motivates Cancer Patients To Enroll Voluntarily In Clinical Trials? Do They Improve Health Outcomes?

Read More

New BIO Conference Welcomes Small, Mid-Caps In 'H&Q' Style

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

InterMune To Restructure Debt With $150M Notes Placement

InterMune Inc. raised $150 million in a private placement of convertible senior notes as part of a plan to reduce its burn rate and narrow its focus in two therapeutic areas. (BioWorld Today) Read More

Corcept Tries Again: Company Files For Estimated $80M IPO

Read More